Reuters logo
BRIEF-pSivida partners with global pharmaceuticals company to develop sustained release formulations of glaucoma drugs
September 26, 2017 / 11:23 AM / in 25 days

BRIEF-pSivida partners with global pharmaceuticals company to develop sustained release formulations of glaucoma drugs

Sept 26 (Reuters) - pSivida Corp:

* pSivida partners with global pharmaceuticals company to develop sustained release formulations of glaucoma drugs

* Terms of partnership includes upfront payments to pSivida of $750,000 for initial development

* Deal also includes potential additional payments totaling $200,000 if all subsequent development activities are conducted Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below